Search research articles
Contact Us
Filters
Showing results (131-140 of 273) with videos related to
Page
of 28
Sort By:
The Journal of Molecular Diagnostics : JMD
|
September 1, 2015
Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers
Wenhsiang Wen, Wangjuh Sting Chen, Nick Xiao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 22, 2005
Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas
B Saffari, L Bernstein, D C Hong, et al.
Nature Genetics
|
February 10, 2015
A Big Bang model of human colorectal tumor growth
Andrea Sottoriva, Haeyoun Kang, Zhicheng Ma, et al.
Breast Cancer Research : BCR
|
June 14, 2012
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries
Michael E Jones, Flora E van Leeuwen, Wilhelmina E Hoogendoorn, et al.
Breast Cancer Research and Treatment
|
June 14, 2011
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger
Mia M Gaudet, Michael F Press, Robert W Haile, et al.
Cancer Research
|
November 21, 2000
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor
J J Park, R A Irvine, G Buchanan, et al.
Cancer Research
|
November 1, 1994
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis
M F Press, M C Pike, G Hung, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
January 19, 1999
p53 mutations and expression in ovarian cancers: correlation with overall survival
W H Wen, A Reles, I B Runnebaum, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 18, 2019
Role for polo-like kinase 4 in mediation of cytokinesis
Michael F Press, Bin Xie, Simon Davenport, et al.
Breast Cancer Research : BCR
|
January 11, 2023
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
Sanne L de Haas, Dennis J Slamon, Miguel Martin, et al.
Page
of 28
Search research articles
Search
Showing results (131-140 of 273) with videos related to
Sort By:
Page
of 28
The Journal of Molecular Diagnostics : JMD
|
September 1, 2015
Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers
Wenhsiang Wen, Wangjuh Sting Chen, Nick Xiao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 22, 2005
Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas
B Saffari, L Bernstein, D C Hong, et al.
Nature Genetics
|
February 10, 2015
A Big Bang model of human colorectal tumor growth
Andrea Sottoriva, Haeyoun Kang, Zhicheng Ma, et al.
Breast Cancer Research : BCR
|
June 14, 2012
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries
Michael E Jones, Flora E van Leeuwen, Wilhelmina E Hoogendoorn, et al.
Breast Cancer Research and Treatment
|
June 14, 2011
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger
Mia M Gaudet, Michael F Press, Robert W Haile, et al.
Cancer Research
|
November 21, 2000
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor
J J Park, R A Irvine, G Buchanan, et al.
Cancer Research
|
November 1, 1994
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis
M F Press, M C Pike, G Hung, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
January 19, 1999
p53 mutations and expression in ovarian cancers: correlation with overall survival
W H Wen, A Reles, I B Runnebaum, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 18, 2019
Role for polo-like kinase 4 in mediation of cytokinesis
Michael F Press, Bin Xie, Simon Davenport, et al.
Breast Cancer Research : BCR
|
January 11, 2023
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
Sanne L de Haas, Dennis J Slamon, Miguel Martin, et al.
Page
of 28